Altered Differentiation of Tendon-Derived Stem Cells in Diabetic Conditions Mediated by Macrophage Migration Inhibitory Factor

被引:11
|
作者
Kim, Du-Hwan [1 ]
Noh, Sun-Up [2 ]
Chae, Seoung-Wan [3 ]
Kim, Sang-Jun [4 ]
Lee, Yong-Taek [2 ,5 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, Seoul 06973, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Med Res Inst, Sch Med, Seoul 03181, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul 03181, South Korea
[4] Seoul Jun Rehabil Clin, Seoul Jun Res Ctr, Seoul 06737, South Korea
[5] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul 03181, South Korea
基金
新加坡国家研究基金会;
关键词
tendinopathy; tendon-derived stem cells; diabetes; macrophage migration inhibitory factor; ACHILLES TENDINOPATHY; BASIC SCIENCE; MELLITUS; INFLAMMATION; ROLES; MIF;
D O I
10.3390/ijms22168983
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of our study was to evaluate the role of macrophage migration inhibitory factor (MIF) in the differentiation of tendon-derived stem cells (TdSCs) under hyperglycemic conditions. In the in vivo experiment, rats were classified into diabetic (DM) and non-DM groups depending on the intraperitoneal streptozotocin (STZ) or saline injection. Twelve-week after STZ injection, the supraspinatus tendon was harvested and prepared for histological evaluation and real-time reverse transcription polymerase chain reaction for osteochondrogenic (aggrecan, BMP-2, and Sox9) and tenogenic (Egr1, Mkx, scleraxis, type 1 collagen, and Tnmd) markers. For the in vitro experiment, TdSCs were isolated from healthy rat Achilles tendons. Cultured TdSCs were treated with methylglyoxal and recombinant MIF or MIF gene knockdown to determine the effect of hyperglycemic conditions and MIF on the differentiation function of TdSCs. These conditions were classified into four groups: hyperglycemic-control group, hyperglycemic-recombinant-MIF group, hyperglycemic-knockdown-MIF group, and normal-control group. The mRNA expression of osteochondrogenic and tenogenic markers was compared among the groups. In the in vivo experiment, the mRNA expression of all osteochondrogenic and tenogenic differentiation markers in the DM group was significantly higher and lower than that in the non-DM group, respectively. Similarly, in the in vitro experiments, the expression of all osteochondrogenic and tenogenic differentiation markers was significantly upregulated and downregulated, respectively, in the hyperglycemic-control group compared to that in the normal-control group. The hyperglycemic-knockdown-MIF group demonstrated significantly decreased expression of all osteochondrogenic differentiation markers and increased expression of only some tenogenic differentiation markers compared with the hyperglycemic-control group. In contrast, the hyperglycemic-recombinant-MIF group showed significantly increased expression of all osteochondrogenic differentiation markers, but no significant difference in any tenogenic marker level, compared to the hyperglycemic-control group. These results suggest that tendon homeostasis could be affected by hyperglycemic conditions, and MIF appears to alter the differentiation of TdSCs via enhancement of the osteochondrogenic differentiation in hyperglycemic conditions. These are preliminary findings, and must be confirmed in a further study.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Role of tendon-derived stem cells in tendon and ligament repair: focus on tissue engineer
    He, Wei
    Jiang, Chao
    Zhou, Ping
    Hu, Xujun
    Gu, Xiaopeng
    Zhang, Songou
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [42] A comparison of the stem cell characteristics of murine tenocytes and tendon-derived stem cells
    Katie Joanna Lee
    Peter David Clegg
    Eithne Josephine Comerford
    Elizabeth Gail Canty-Laird
    BMC Musculoskeletal Disorders, 19
  • [43] Macrophage migration inhibitory factor (MIF) and cell differentiation
    Kobayashi, S
    Yoshida, K
    Longenecker, G
    Satomura, K
    Levsky, JM
    Semba, I
    Sreenath, T
    Wistow, GJ
    Shum, L
    Slavkin, HC
    Kulkarni, AB
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 437A - 437A
  • [44] Engineered scaffold-free tendon tissue produced by tendon-derived stem cells
    Ni, Ming
    Rui, Yun Feng
    Tan, Qi
    Liu, Yang
    Xu, Liang Liang
    Chan, Kai Ming
    Wang, Yan
    Li, Gang
    BIOMATERIALS, 2013, 34 (08) : 2024 - 2037
  • [45] Enhancement of Tendon Repair Using Tendon-Derived Stem Cells in Small Intestinal Submucosa via M2 Macrophage Polarization
    Mao, Xufeng
    Yao, Liwei
    Li, Mei
    Zhang, Xiqian
    Weng, Bowen
    Zhu, Weilai
    Ni, Renhao
    Chen, Kanan
    Yi, Linhua
    Zhao, Jiyuan
    Mao, Haijiao
    CELLS, 2022, 11 (17)
  • [46] Intramuscular injection of Botox causes tendon atrophy by induction of senescence of tendon-derived stem cells
    Chen, Peilin
    Chen, Ziming
    Mitchell, Christopher
    Gao, Junjie
    Chen, Lianzhi
    Wang, Allan
    Leys, Toby
    Landao-Bassonga, Euphemie
    Zheng, Qiujian
    Wang, Tao
    Zheng, Minghao
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [47] A New Tissue Engineering Strategy to Promote Tendon-bone Healing: Regulation of Osteogenic and Chondrogenic Differentiation of Tendon-derived Stem Cells
    Shen, Sinuo
    Lin, Yucheng
    Sun, Jiachen
    Liu, Yuanhao
    Chen, Yuzhi
    Lu, Jun
    ORTHOPAEDIC SURGERY, 2024, 16 (10) : 2311 - 2325
  • [48] Intramuscular injection of Botox causes tendon atrophy by induction of senescence of tendon-derived stem cells
    Peilin Chen
    Ziming Chen
    Christopher Mitchell
    Junjie Gao
    Lianzhi Chen
    Allan Wang
    Toby Leys
    Euphemie Landao-Bassonga
    Qiujian Zheng
    Tao Wang
    Minghao Zheng
    Stem Cell Research & Therapy, 12
  • [49] Tendon-Derived Extracellular Matrix Enhances Transforming Growth Factor-β3-Induced Tenogenic Differentiation of Human Adipose-Derived Stem Cells
    Yang, Guang
    Rothrauff, Benjamin B.
    Lin, Hang
    Yu, Shuting
    Tuan, Rocky S.
    TISSUE ENGINEERING PART A, 2017, 23 (3-4) : 166 - 176
  • [50] Bevacizumab promotes tenogenic differentiation and maturation of rat tendon-derived cells in vitro
    Kusaba, Yohei
    Kumagai, Ken
    Ishikawa, Kimi
    Choe, Hyonmin
    Ike, Hiroyuki
    Kobayashi, Naomi
    Inaba, Yutaka
    PLOS ONE, 2023, 18 (10):